EP2641629A1 — Medical injection device with injection site pain reduction device
Assigned to Sanofi Aventis Deutschland GmbH · Expires 2013-09-25 · 13y expired
What this patent protects
Described is a medicament injection device (100) comprising a housing (102) containing a syringe (300), a pain reduction device (200) coupled to the housing (102), a coupling mechanism (110) disposed in the housing (102) and operably coupled to the pain reduction device (200), an…
USPTO Abstract
Described is a medicament injection device (100) comprising a housing (102) containing a syringe (300), a pain reduction device (200) coupled to the housing (102), a coupling mechanism (110) disposed in the housing (102) and operably coupled to the pain reduction device (200), and a drive mechanism (106) disposed in the housing (102) and operably coupled to the coupling mechanism (110). Activation of the drive mechanism (106) actuates the coupling mechanism (110) to activate the pain reduction device (200), which either releases a pain reduction agent or alternatively cools or heats the skin region adjacent the injection site.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.